RhumbLine Advisers’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-564,642
Closed -$42.7M 4190
2026
Q1
$42.7M Buy
564,642
+13,871
+3% +$1.04M 0.04% 406
2025
Q4
$41M Buy
550,771
+2,423
+0.4% +$177K 0.03% 432
2025
Q3
$37M Buy
548,348
+4,142
+0.8% +$275K 0.03% 482
2025
Q2
$35.5M Buy
544,206
+8,858
+2% +$531K 0.03% 473
2025
Q1
$33.1M Buy
535,348
+25,822
+5% +$1.71M 0.03% 471
2024
Q4
$36.7M Sell
509,526
-5,510
-1% -$430K 0.03% 437
2024
Q3
$42M Buy
515,036
+2,241
+0.4% +$179K 0.04% 398
2024
Q2
$38.1M Buy
512,795
+10,569
+2% +$792K 0.04% 397
2024
Q1
$39.2M Sell
502,226
-14,430
-3% -$1.07M 0.04% 398
2023
Q4
$36.9M Sell
516,656
-17,339
-3% -$1.21M 0.04% 402
2023
Q3
$37.1M Sell
533,995
-2,545
-0.5% -$192K 0.04% 360
2023
Q2
$43.4M Sell
536,540
-11,909
-2% -$973K 0.05% 335
2023
Q1
$44.3M Buy
548,449
+23,396
+4% +$1.88M 0.05% 318
2022
Q4
$39.3M Buy
525,053
+23,175
+5% +$1.65M 0.05% 332
2022
Q3
$32.4M Sell
501,878
-5,118
-1% -$355K 0.05% 357
2022
Q2
$35.1M Buy
506,996
+78,608
+18% +$5.84M 0.05% 327
2022
Q1
$32.9M Buy
428,388
+2,573
+0.6% +$185K 0.04% 370
2021
Q4
$32.6M Sell
425,815
-5,517
-1% -$406K 0.04% 396
2021
Q3
$31.8M Sell
431,332
-19,025
-4% -$1.43M 0.04% 379
2021
Q2
$30M Sell
450,357
-27,327
-6% -$1.83M 0.04% 418
2021
Q1
$35.5M Sell
477,684
-32,543
-6% -$2.47M 0.05% 341
2020
Q4
$37.2M Sell
510,227
-16,250
-3% -$1.15M 0.05% 314
2020
Q3
$35M Sell
526,477
-25,615
-5% -$1.62M 0.05% 302
2020
Q2
$31.5M Sell
552,092
-55,765
-9% -$2.74M 0.05% 321
2020
Q1
$21.3M Buy
607,857
+20,563
+4% +$979K 0.04% 370
2019
Q4
$30.7M Buy
587,294
+33,082
+6% +$1.65M 0.05% 330
2019
Q3
$28M Buy
554,212
+1,681
+0.3% +$82.7K 0.05% 335
2019
Q2
$26.5M Buy
552,531
+76,294
+16% +$3.53M 0.05% 354
2019
Q1
$23.1M Sell
476,237
-36,582
-7% -$1.65M 0.04% 391
2018
Q4
$21.1M Buy
512,819
+140
+0% +$5.74K 0.05% 393
2018
Q3
$21M Sell
512,679
-4,638
-0.9% -$187K 0.04% 429
2018
Q2
$20.6M Sell
517,317
-31,868
-6% -$1.23M 0.04% 427
2018
Q1
$20.5M Sell
549,185
-10,911
-2% -$441K 0.04% 421
2017
Q4
$23.9M Sell
560,096
-14,706
-3% -$587K 0.05% 389
2017
Q3
$21.1M Buy
574,802
+26,337
+5% +$1.06M 0.05% 407
2017
Q2
$24.9M Buy
548,465
+7,727
+1% +$341K 0.06% 339
2017
Q1
$23M Buy
540,738
+12,277
+2% +$501K 0.05% 352
2016
Q4
$21.2M Buy
528,461
+79,285
+18% +$3.06M 0.05% 357
2016
Q3
$17.4M Buy
449,176
+37,098
+9% +$1.4M 0.05% 383
2016
Q2
$14.3M Buy
412,078
+192,405
+88% +$6.66M 0.04% 414
2016
Q1
$7.58M Sell
219,673
-196,659
-47% -$6.86M 0.02% 644
2015
Q4
$16.1M Buy
416,332
+7,135
+2% +$278K 0.05% 355
2015
Q3
$16M Buy
409,197
+17,103
+4% +$678K 0.05% 345
2015
Q2
$14.9M Buy
392,094
+55,430
+16% +$1.94M 0.05% 385
2015
Q1
$11.1M Buy
336,664
+29,905
+10% +$918K 0.03% 486
2014
Q4
$8.2M Buy
306,759
+4,785
+2% +$124K 0.02% 565
2014
Q3
$7.35M Sell
301,974
-18,643
-6% -$471K 0.02% 582
2014
Q2
$8.13M Sell
320,617
-55,097
-15% -$1.29M 0.02% 566
2014
Q1
$8.08M Sell
375,714
-4,020
-1% -$86.7K 0.02% 587
2013
Q4
$8.49M Sell
379,734
-41,072
-10% -$906K 0.03% 560
2013
Q3
$8.69M Buy
420,806
+2,596
+0.6% +$55.3K 0.03% 547
2013
Q2
$8.07M Buy
+418,210
New +$8.74M 0.03% 546

Other funds holding HOLX

RhumbLine Advisers's HOLX Position: Q2 2026 in Review

RhumbLine Advisers sold out of Hologic (HOLX) in Q2 2026, closing a stake of 564,642 shares — an estimated $42.7M sold.

RhumbLine Advisers first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $44.3M in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • RhumbLine Advisers reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 564,642 Hologic shares in Q2 2026, an estimated $42.7M.
  • RhumbLine Advisers first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • RhumbLine Advisers's Hologic position peaked at $44.3M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.